share_log
Moomoo 24/7 ·  Apr 17 16:08
DiaMedica Therapeutics Doses First Patient Relaunch Of Pivotal Phase 2/3 ReMEDy2 Trial Of DM199 For Acute Ischemic Stroke
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment